Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac allograft vasculopathy

P B Pfeifer1, E G Collins

  • 1Nursing Service, Department of Veteran Affairs, Edward Hines, Jr. Hospital Hines, Illinois.

The Journal of Cardiovascular Nursing
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Equipment, access and worry about running short of oxygen: Key concerns in the ATS patient supplemental oxygen survey.

Heart & lung : the journal of critical care·2019
Same author

BRAIN ABSCESS WITH UNUSUAL FEATURES: REPORT OF TWO CASES.

British medical journal·2010
Same author

Ear-Nose-Throat Casualties in the Middle East.

British medical journal·2010
Same author

Physiological improvement with moderate exercise in type II diabetic neuropathy.

Electromyography and clinical neurophysiology·2007
Same author

Patients' perspective on the comprehensive preventive health evaluation in veterans with spinal cord injury.

Spinal cord·2005
Same author

Breathing pattern retraining and exercise in persons with chronic obstructive pulmonary disease.

AACN clinical issues·2002
Same journal

Predictors of Prolonged Intensive Care Unit Stay After Heart Valve Surgery: A Case-Control Study.

The Journal of cardiovascular nursing·2026
Same journal

Characteristics and Care Practices in People Hospitalized for Heart Failure With Coexisting Diabetes: A Single-Center Retrospective Observational Study.

The Journal of cardiovascular nursing·2026
Same journal

Association of a Diet Index for the Gut Microbiome With Hypertension and Obesity-Related Hypertension: A Cross-Sectional Analysis of NHANES 2007-2020.

The Journal of cardiovascular nursing·2026
Same journal

Device-Assessed Physical Activity and Cardiometabolic Health in Chinese American Women With a History of Gestational Diabetes Mellitus.

The Journal of cardiovascular nursing·2026
Same journal

Physical Frailty, Self-Care Behaviors, and 6-Month Clinical Outcomes Among Adults With Heart Failure.

The Journal of cardiovascular nursing·2026
Same journal

Challenges Experienced by Patients With Chronic Venous Disease in Unresolved Postoperative Recovery After Iliac Vein Stenting: A Phenomenological Study.

The Journal of cardiovascular nursing·2026
See all related articles

Cardiac allograft vasculopathy (CAV) is a serious complication after heart transplants, affecting graft survival. This review covers CAV

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • Improving survival rates in cardiac transplant patients highlight long-term complications.
  • Cardiac allograft vasculopathy (CAV) is a significant cause of graft loss.
  • CAV is a form of coronary artery disease unique to transplant recipients.

Purpose of the Study:

  • To explore the pathophysiology, risk factors, detection, and treatment of CAV.
  • To increase awareness of CAV as a critical post-transplant complication.
  • To provide a comprehensive overview for clinicians managing cardiac transplant recipients.

Main Methods:

  • Review of existing literature on cardiac allograft vasculopathy.
  • Analysis of immune-related responses and other contributing factors.
  • Discussion of current and emerging diagnostic techniques.

Related Experiment Videos

Main Results:

  • CAV develops early post-transplant, often undetected initially.
  • Estimated incidence of 12% per year in cardiac transplant recipients.
  • Primarily an immune response, but hyperlipidemia and obesity are risk factors.

Conclusions:

  • CAV is a major impediment to long-term cardiac allograft survival.
  • Early detection and management are crucial.
  • Understanding risk factors aids in prevention and treatment strategies.